Societal CDMO Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - The analyst’s summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Societal CDMO Inc (Societal CDMO), a subsidiary of CoRex Inc, is a contract development and manufacturing organization (CDMO) specializing in the pharmaceutical sector. The company's primary activities include the development and manufacturing of modified-release formulations, including those for high potent and DEA controlled substances. Societal CDMO offers an array of services such as analytical services, packaging and logistics, manufacturing, formulation development, and regulatory support. The company’s services are utilized by pharmaceutical companies for drug development, repurposing, reformulation strategies, and commercial manufacturing. The company has manufacturing facilities located in Gainesville, Georgia, and San Diego, California. Societal CDMO is headquartered in Gainesville, Georgia, the US.Societal CDMO Inc Key Recent Developments
- Nov 08, 2023: Societal CDMO Reports Third Quarter 2023 Financial Results
- Sep 20, 2023: Societal Announces Corporate Restructuring
- Sep 07, 2023: Societal CDMO Secures Project Expansion Agreements With Several Existing Customers
- Aug 23, 2023: Societal CDMO Announces Appointment of Matt Arens to Board of Directors
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company’s Lifesciences Financial Deals and Alliances
Section 4 - Company’s Recent Developments
Section 5 - Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Quotient Sciences Ltd
- Catalent Inc
- Recipharm AB
- Corden Pharma International GmbH
- Pharmaceutics International Inc
- Avara Pharmaceutical Services Inc